Drug Type Tregs cell therapy |
Synonyms- |
Target |
Mechanism NCOA3 modulators(nuclear receptor coactivator 3 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Preclinical | US | 24 Aug 2024 | |
Lung Cancer | Preclinical | US | 24 Aug 2024 | |
Pancreatic Cancer | Preclinical | US | 24 Aug 2024 | |
Prostatic Cancer | Preclinical | US | 24 Aug 2024 | |
Triple Negative Breast Cancer | Preclinical | US | 24 Aug 2024 |